Trabecular Micro-Bypass Shunt (istent (R): Basic Science, Clinical, and Future)

被引:13
|
作者
Craven, E. Randy [1 ]
机构
[1] King Khalid Eye Specialist Hosp, Glaucma Div, POB 7191, Riyadh 11462, Saudi Arabia
关键词
Glaucoma Surgery; Hydrus; iStent; Micro-Invasive Glaucoma Surgery; Trabecular Bypass Stent;
D O I
10.4103/0974-9233.148346
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The trabecular bypass stent offers an alternative to filtration surgery. Patients who may be ideal candidates for considering this procedure are those with prior conjunctival surgery; for example, those who had a 360 degrees peritomy from a scleral buckle might not do well with a trabeculectomy and there is no space for a tube. Highly myopic patients do not tolerate hypotony well, and the iSTB may be an option for some of these patients. I have used the iSTB in patients on anticoagulants who could not stop them, and they needed something beyond medications and laser to lower the IOP in subjects with open-angle glaucoma. Young patients, especially those with one eye, who need rapid visual recovery (for instance to return to work) may be good candidates to consider the iSTB as well. Because of the position used for clear corneal cataract surgery, the temporal approach is best for doing these. Therefore, if you are doing cataract surgery on someone who needs a lower IOP, you already are in the correct position to implant the devices. Patients may need some medications after the procedure to lower the IOP to the level desired. The results from Armenia are encouraging, given an IOP of 11.8 mmHg after 2 iSTB stents and taking daily travoprost. These results are difficult to reach even with a trabeculectomy. When selecting your fist patients, avoid those with the congested episcleral veins, look for patients with wide open angles, and if you can see aqueous veins at the slit-lamp it may indicate a viable outflow system. Probably avoid patients with IOPs over 35 mmHg. The micro-invasive trabecular bypass stents offer an alternative surgical intervention for select patients with open-angle glaucoma. Recent studies show that combining these micro-stents with medications can lead to as low of an intraocular pressure (IOP) as is achieved by many more invasive incisional surgeries. The technique is quite precise and learning the procedure is similar to clear corneal phacoemulsification followed by a goniotomy. Long-term data are starting to come in and the safety is favorable. The IOP success appears to be based on the patency of the outflow system for a given patient. Key factors in determining the success involve the placement of trabecular bypass devices into the canal of Schlemm and require a down-stream patency of the collector channel system and a low episcleral venous pressure. Because accessing the collector system may require placement by a patent channel, the placement of two stents, a longer stent with scaffolding or somehow imaging the outflow system may lead to the best control of the IOP.
引用
收藏
页码:30 / 37
页数:8
相关论文
共 50 条
  • [21] Standalone Implantation of 2–3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma
    Ricardo Augusto Paletta Guedes
    Daniela Marcelo Gravina
    Vanessa Maria Paletta Guedes
    Alfredo Chaoubah
    Ophthalmology and Therapy, 2022, 11 : 271 - 292
  • [22] Surgical outcomes of trabecular micro-bypass (iStent) surgery performed by ophthalmology resident trainees compared to attending surgeons
    Moster, Stephen
    Zheng, Cindy X.
    Lin, Michael
    Copparam, Saumya
    Lee, Daniel
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [23] Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma
    Detlev Spiegel
    Wolfgang Wetzel
    David S. Haffner
    Richard A. Hill
    Advances in Therapy, 2007, 24 : 161 - 170
  • [24] Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma
    Spiegel, Detlev
    Wetzel, Wolfgang
    Haffner, David S.
    Hill, Richard A.
    ADVANCES IN THERAPY, 2007, 24 (01) : 161 - 170
  • [25] iSTENT MICRO-TRABECULAR BYPASS SHUNT: EARLY RESULTS FROM A PROSPECTIVE UK SERIES
    de Klerk, Timothy A.
    Patel, Ilesh
    Au, Leon
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 12 - 12
  • [26] Standalone Implantation of 2-3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma
    Paletta Guedes, Ricardo Augusto
    Gravina, Daniela Marcelo
    Paletta Guedes, Vanessa Maria
    Chaoubah, Alfredo
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (01) : 271 - 292
  • [27] Outcomes of Combined iStent Trabecular Micro-Bypass and Cataract Surgery for the Treatment of Open-Angle Glaucoma in a Saudi Population
    Al Habash, Ahmed
    Khan, Omar
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 1573 - 1580
  • [28] Mid-Term Evaluation of iStent Inject® Trabecular Micro-Bypass Stent Implantation with or without Phacoemulsification: A Retrospective Study
    Silveira Seixas, Regina Cele
    Balbino, Marcos
    Neto, Alberto Basile
    Almeida Costa, Amanda de Alcantara
    da Silva Jordao, Marcelo Lopes
    Abil Russ, Heloisa Helena
    CLINICAL OPHTHALMOLOGY, 2020, 14 : 4403 - 4413
  • [29] iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control
    Hengerer, Fritz H.
    Auffarth, Gerd U.
    Conrad-Hengerer, Ina
    ADVANCES IN THERAPY, 2022, 39 (03) : 1417 - 1431
  • [30] Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia
    Ordonez, Jaime E.
    Ordonez, Angelica
    Osorio, Urpy M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (02) : 329 - 340